Press Releases

Apr 12, 2026

Nina Shah

Press Releases

Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Consolidation LBCL

Allogene Therapeutics announced encouraging interim futility analysis results from its Phase 2 ALPHA3 trial evaluating cemacabtagene ansegedleucel (cema-cel), an allogeneic CAR T therapy, in first-line consolidation for large B-cell lymphoma (LBCL). The cema-cel arm showed a 58.3% minimal residual disease (MRD) clearance rate versus 16.7% in the ob…

ALLO

Apr 12, 2026

Avery Klein

Press Releases

BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners

BullFrog AI Holdings announced a significant commercial feasibility agreement with a top 5 global pharmaceutical company to use its AI platform bfLEAP® to identify novel drug targets in major depressive disorder. The company also strengthened its balance sheet with recent financings to support operations into late 2027 and is advancing multiple dis…

BFRG

Apr 12, 2026

Derek Hwang

Press Releases

ASP Isotopes Inc. Provides Business Update

ASP Isotopes Inc. presents a comprehensive business update highlighting operational milestones across its nuclear medicine, electronics, and nuclear energy platforms. The company anticipates first commercial shipments of several enriched isotopes including Silicon-28, Carbon-14, and Ytterbium-176 in 2026, expects to reach helium production capacity…

ASPI

Apr 12, 2026

Leila Farooq

Press Releases

Palvella Therapeutics Appoints John D. Doux, M.D., M.B.A., Dermatologist and Recognized Leader in Rare Skin Diseases, to Board of Directors

Palvella Therapeutics, a clinical-stage biopharmaceutical company specializing in rare skin diseases and vascular malformations, announced the appointment of John D. Doux, M.D., M.B.A., a recognized dermatologist and investor in rare skin disease therapies, to its Board of Directors. Dr. Doux's deep medical experience and previous advocacy for inno…

PVLA

Apr 12, 2026

Priya Menon

Press Releases

NorthStrive Biosciences Announces U.S. Arrival of EL-32 Working Cell Bank and Initiation of Manufacturing Optimization for Dual Myostatin Assets Targeting Muscle Preservation with GLP-1 Therapies in Collaboration with Modulant Biosciences

PMGC Holdings Inc.'s subsidiary NorthStrive Biosciences announces the successful transfer of the EL-32 Working Cell Bank to a U.S.-based fermentation facility, initiating manufacturing optimization aimed at scalable and cost-effective production. EL-32 is an engineered probiotic therapeutic targeting muscle preservation by modulating myostatin and …

ELAB

Apr 12, 2026

Nina Shah

Press Releases

Hillman Acquires Delaney Hardware; Expands Pro Distribution Categories Adding Door Hardware

Hillman Solutions Corp. announced the acquisition of Delaney Hardware, a U.S.-based door hardware supplier serving residential, multifamily, and commercial construction markets. This acquisition strategically expands Hillman's pro distribution categories by adding door hardware products and broadens its builder's hardware inventory. The company exp…

HLMN

Apr 12, 2026

Sofia Navarro

Press Releases

3D Systems Accelerates Production-Scale Additive Manufacturing with New High-Throughput Platform and Next-Generation Factory Software

3D Systems has unveiled its next-generation SLA 825 Dual stereolithography system offering 22% larger build volume and up to 25% faster print speeds to enhance production throughput. Alongside, it launched AddiTrak™, an advanced on-premises factory software platform for real-time fleet monitoring and process control. These innovations aim to accele…

DDD

Apr 12, 2026

Jordan Park

Press Releases

Oil-Dri Corporation of America Named a 2026 USA TODAY Top Workplaces Winner

Oil-Dri Corporation of America (NYSE: ODC) was named a 2026 USA TODAY Top Workplaces winner, an accolade based on confidential employee feedback showcasing the company's commitment to a collaborative and supportive work environment. This recognition highlights Oil-Dri's people-first culture, emphasizing transparency, employee engagement, and opport…

ODC

Apr 12, 2026

Priya Menon

Press Releases

Akebia Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of AKB-9090

Akebia Therapeutics has dosed the first participants in a Phase 1 clinical trial of AKB-9090, an internally developed HIF-PH inhibitor aimed at treating cardiac surgery-associated acute kidney injury (AKI). The randomized, double-blind, placebo-controlled study will assess safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy adul…

AKBA

Apr 12, 2026

Derek Hwang

Press Releases

Daraxonrasib Demonstrates Unprecedented Overall Survival Benefit in Pivotal Phase 3 RASolute 302 Clinical Trial in Patients with Metastatic Pancreatic Cancer

Revolution Medicines announced positive topline results from the RASolute 302 Phase 3 clinical trial evaluating daraxonrasib, an oral targeted therapy, in previously treated metastatic pancreatic ductal adenocarcinoma patients. The trial met all primary and key secondary endpoints, showing a significant improvement in progression-free survival and …

RVMD

Apr 12, 2026

Derek Hwang

Press Releases

CVRx Reports Preliminary First Quarter 2026 Financial Results

CVRx, Inc. announced preliminary unaudited financial results for Q1 2026, reporting approximately 20% revenue growth year over year to $14.7-$14.8 million. The company noted improvements in Medicare Advantage prior authorization approval rates following implementation of Category I CPT codes, and activated the first site in the BENEFIT-HF clinical …

CVRX

Apr 12, 2026

Caleb Monroe

Press Releases

Eupraxia Pharmaceuticals to Present at Upcoming Investor Conferences

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company specializing in local, controlled drug delivery using its Diffusphere™ technology, announced participation in upcoming investor conferences in New York and Toronto. The company is advancing clinical trials for its lead products, including EP-104GI for eosinophilic esophagitis and…

EPRX

Apr 12, 2026

Ajmal Hussain

Press Releases

Enphase Energy Expands Commercial Microinverter Deployments Across the United States

Enphase Energy announced increased shipments of advanced commercial microinverters manufactured in the U.S., including the new IQ9N-3P model designed for three-phase commercial solar installations. These products comply with domestic content rules to qualify for federal tax credits and are being adopted for commercial and repowering solar projects …

ENPH

Apr 12, 2026

Ajmal Hussain

Press Releases

Elite Express Holding Inc. Reports First Quarter 2026 Results

Elite Express Holding Inc. reported first quarter 2026 financial results showing a 16.3% year-over-year revenue increase to $805,298 and a 46.3% reduction in net loss to $110,104. Improvements were driven by increased delivery volumes, better route and fleet management, and labor efficiency. The renewal of its ISP agreement with FedEx contributed t…

ETS

Apr 12, 2026

Marcus Reed

Press Releases

Copa Holdings Announces Monthly Traffic Statistics for March 2026

Copa Holdings announced a significant increase in passenger traffic for March 2026, with available seat miles up 14.8% and revenue passenger miles up 15.3% compared to March 2025. The company also achieved a higher load factor of 86.7%.

CPA

Apr 12, 2026

Ajmal Hussain

Press Releases

BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare Conference

BrainsWay Ltd., a leader in noninvasive neurostimulation treatments for mental health disorders, will present at the 25th Annual Needham Virtual Healthcare Conference on April 15, 2026. The company continues to build awareness for its FDA-cleared Deep Transcranial Magnetic Stimulation (Deep TMS) technology, which treats major depressive disorder, O…

BWAY

Apr 12, 2026

Nina Shah

Press Releases

Lamar Advertising Company to Release First Quarter Ended March 31, 2026 Operating Results

Lamar Advertising Company announced that it will release its first quarter ended March 31, 2026 operating results before the market opens on May 7, 2026. The company will host a conference call on the same day to discuss the results and company operations.

LAMR

Apr 12, 2026

Derek Hwang

Press Releases

Par Pacific Announces First Quarter 2026 Earnings Release and Conference Call Schedule

Par Pacific Holdings, Inc. announced it will release its Q1 2026 earnings after NYSE closes on May 5, 2026, followed by a conference call on May 6, 2026. The company operates refining, energy infrastructure, retail fuel brands, and a stake in natural gas production.

PARR

Apr 12, 2026

Nina Shah

Press Releases

HighPeak Energy, Inc. to Present at the Water Tower Research Insights Conference on April 15, 2026

HighPeak Energy, Inc., an independent oil and natural gas exploration company focused in the Midland Basin, announced its participation in the Water Tower Research Insights Conference with virtual presentations by CEO Michael Hollis and EVP Ryan Hightower. The event aims to enhance investor communications and engagement, featuring companies from va…

HPK

Apr 12, 2026

Jordan Park

Press Releases

VisionWave Acquires xClibre™ AI Video Intelligence IP Assets

VisionWave Holdings, a Nasdaq-listed defense technology company, has acquired the xClibre AI video intelligence intellectual property valued at approximately $60 million. The acquisition enhances VisionWave's sensing architecture by adding AI-driven video analytics to their existing RF-based detection systems. The company plans to integrate xClibre…

VWAV

Apr 12, 2026

Maya Rios

Press Releases

Orrstown Financial Services, Inc. Announces Date of First Quarter 2026 Earnings Release, Conference Call and Webcast

Orrstown Financial Services, Inc. announced that it will release its first quarter 2026 earnings report after market close on April 21, 2026. The company will hold a conference call and webcast on April 22, 2026, for management to review the quarterly results with investors and analysts.

ORRF

Apr 12, 2026

Hana Yamamoto

Press Releases

Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism

Septerna, Inc., a clinical-stage biotech company focused on GPCR drug discovery, has initiated a Phase 1 clinical trial for SEP-479, an oral small molecule PTH1R agonist designed to treat hypoparathyroidism. The trial will assess safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy volunteers, with data expected by late 2026 or e…

SEPN

Apr 12, 2026

Avery Klein

Press Releases

Bitcoin Depot Appoints New Compliance Officer, Tony Gagliardi

Bitcoin Depot announced the hiring of Tony Gagliardi as Chief Compliance Officer to lead and enhance the company's compliance framework amid evolving regulatory requirements. Gagliardi brings over 15 years of experience across financial services and digital assets, overseeing anti-money laundering, Know-Your-Customer programs, and state-level regul…

BTM

Apr 12, 2026

Hana Yamamoto

Press Releases

Howard Hughes Holdings Inc. Announces Dates and Times for 2026 First Quarter Earnings Release and Conference Call

Howard Hughes Holdings Inc. announced it will release its first quarter 2026 earnings on May 7, 2026, after market close, followed by a conference call on May 8, 2026. The company is a US-based real estate holding company with a portfolio of master planned communities and development projects across multiple US regions.

HHH

Apr 12, 2026

Caleb Monroe

Press Releases

OSS to Support Network of Autonomous Energy Nodes for Emerging Alternative Energy-Powered Data Center Company

One Stop Systems, Inc. (NASDAQ: OSS) announced a purchase order exceeding $500,000 from a renewable-energy tech firm developing a network of autonomous energy nodes powering onboard AI compute payloads. This marks the start of a projected multi-year relationship with follow-on orders exceeding $1 million annually, potentially scaling to $10 million…

OSS